This inventor holds 3 USPTO granted patents. Top assignees: Bissendorf Peptide Gmbh, Forschungszentrum Julich Gmbh, Pharma Biotechnologie Hannover Gmbh. Active years: 1989-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hannover, DE (1993)
- Hanover, DE (1989 - 1999)
Company Filing History:

Years Active: 1989-1999
Title: Innovations by Hans-Joachim Schmoll
Introduction
Hans-Joachim Schmoll is a notable inventor based in Hanover, Germany. He has made significant contributions to the field of biotechnology, particularly in the cultivation of organ-function cells. With a total of 3 patents, his work has advanced the understanding and application of cell culture techniques.
Latest Patents
One of Schmoll's latest patents involves culturing cells on macroporous glass carriers coated with gelatin. This innovative method allows for the cultivation of stem cells or other organ-function cells in a fluidized bed system. The process includes treating glass carrier bodies with structural proteins and extracellular matrix proteins, creating an optimal environment for cell immobilization and growth. Another patent describes a method and device for the local application and removal of active substances against solid tumors. This device utilizes a catheter system to collect and return blood while allowing for the application of therapeutic agents.
Career Highlights
Throughout his career, Hans-Joachim Schmoll has worked with various companies, including Bissendorf Peptide GmbH and Forschungszentrum Jülich GmbH. His experience in these organizations has contributed to his expertise in biotechnology and cell culture methodologies.
Collaborations
Schmoll has collaborated with notable individuals in his field, including Ekkehard Schmoll and Edmund R. Lax. These partnerships have likely enriched his research and development efforts.
Conclusion
Hans-Joachim Schmoll's innovative work in cell culture and biotechnology has led to significant advancements in the field. His patents reflect a commitment to improving methods for cultivating organ-function cells and addressing medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile